Comparative polar and lipid plasma metabolomics differentiate KSHV infection and disease states.

Comparative polar and lipid plasma metabolomics differentiate KSHV infection and disease states.
复制标题

DOI:
10.1186/s40170-023-00316-0
复制
发表时间:
2023-08-31
影响因子:
5.9
通讯作者:
--
中科院分区:
医学3区
文献类型:
--
作者:

文献摘要

参考文献

相似文献

Kaposi sarcoma (KS) is a neoplastic disease etiologically associated with infection by the Kaposi sarcoma-associated herpesvirus (KSHV). KS manifests primarily as cutaneous lesions in individuals due to either age (classical KS), HIV infection (epidemic KS), or tissue rejection preventatives in transplantation (iatrogenic KS) but can also occur in individuals, predominantly in sub-Saharan Africa (SSA), lacking any obvious immune suppression (endemic KS). The high endemicity of KSHV and human immunodeficiency virus-1 (HIV) co-infection in Africa results in KS being one of the top 5 cancers there. As with most viral cancers, infection with KSHV alone is insufficient to induce tumorigenesis. Indeed, KSHV infection of primary human endothelial cell cultures, even at high levels, is rarely associated with long-term culture, transformation, or growth deregulation, yet infection in vivo is sustained for life. Investigations of immune mediators that distinguish KSHV infection, KSHV/HIV co-infection, and symptomatic KS disease have yet to reveal consistent correlates of protection against or progression to KS. In addition to viral infection, it is plausible that pathogenesis also requires an immunological and metabolic environment permissive to the abnormal endothelial cell growth evident in KS tumors. In this study, we explored whether plasma metabolomes could differentiate asymptomatic KSHV-infected individuals with or without HIV co-infection and symptomatic KS from each other. To investigate how metabolic changes may correlate with co-infections and tumorigenesis, plasma samples derived from KSHV seropositive sub-Saharan African subjects in three groups, (A) asymptomatic (lacking neoplastic disease) with KSHV infection only, (B) asymptomatic co-infected with KSHV and HIV, and (C) symptomatic with clinically diagnosed KS, were subjected to analysis of lipid and polar metabolite profiles Polar and nonpolar plasma metabolic differentials were evident in both comparisons. Integration of the metabolic findings with our previously reported KS transcriptomics data suggests dysregulation of amino acid/urea cycle and purine metabolic pathways, in concert with viral infection in KS disease progression. This study is, to our knowledge, the first to report human plasma metabolic differentials between in vivo KSHV infection and co-infection with HIV, as well as differentials between co-infection and epidemic KS. The online version contains supplementary material available at 10.1186/s40170-023-00316-0.
DOI: 10.3390/cancers13225692
发表时间: 2021-11-14
期刊: Cancers
影响因子: 5.2
作者:
Grabar S;Costagliola D
通讯作者: Costagliola D
利用氧化还原的破坏来治疗相关的人类疱疹病毒8(HHV-8)。
DOI: 10.3390/antiox12010084
发表时间: 2022-12-30
期刊: Antioxidants (Basel, Switzerland)
影响因子: --
作者:
通讯作者: --
DOI: 10.1038/srep38881
发表时间: 2016-12-13
期刊: Scientific reports
影响因子: 4.6
作者:
Li B;Tang J;Yang Q;Cui X;Li S;Chen S;Cao Q;Xue W;Chen N;Zhu F
通讯作者: Zhu F
DOI: 10.1177/1099800417747411
发表时间: 2018-03
影响因子: 2.5
作者:
Lyon DE;Starkweather A;Yao Y;Garrett T;Kelly DL;Menzies V;Dereziński P;Datta S;Kumar S;Jackson-Cook C
通讯作者: Jackson-Cook C
DOI: 10.1073/pnas.1004882107
发表时间: 2010-06-08
影响因子: 11.1
作者:
Delgado, Tracie;Carroll, Patrick A.;Lagunoff, Michael
通讯作者: Lagunoff, Michael